Research Alliance Corp. II Class A Common Stock
RACB
RACB was delisted on the 1st of December, 2022.
39 hedge funds and large institutions have $139M invested in Research Alliance Corp. II Class A Common Stock in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 9 closing their positions.
133% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 3
0% less capital invested
Capital invested by funds: $140M → $139M (-$695K)
0.78% less ownership
Funds ownership: 92.62% → 91.84% (-0.78%)
3% less funds holding
Funds holding: 40 → 39 (-1)
11% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Saba Capital Management
New York
|
+$18.7M |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$5.87M |
| 3 |
SC
Sculptor Capital
New York
|
+$3.81M |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$3.28M |
| 5 |
MTCM
Mint Tower Capital Management
Amsterdam,
Netherlands
|
+$1.42M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HM
HealthCor Management
New York
|
-$12.9M |
| 2 |
PA
Perceptive Advisors
New York
|
-$9.76M |
| 3 |
FCMV
Foresite Capital Management V
Larkspur,
California
|
-$4.88M |
| 4 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$4.2M |
| 5 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$3.07M |
RACB Hedge Fund Activity: Q2 2022 in Review
39 of the 5,960 institutional investors tracked by Wall St. Rank reported a position in Research Alliance Corp. II Class A Common Stock (RACB) for Q2 2022, worth a combined $139M — down 0.5% from $140M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of RACB and 8 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 7 added.
The largest buyer was Saba Capital Management, opening a new position worth an estimated $18.7M. The largest seller was HealthCor Management, exiting entirely with an estimated $12.9M sold.
- 39 institutional investors held Research Alliance Corp. II Class A Common Stock (RACB) as of Q2 2022, down from 40 in Q1 2022.
- Funds reported $139M of Research Alliance Corp. II Class A Common Stock stock for Q2 2022, down 0.5% quarter-over-quarter.
- 8 funds opened new Research Alliance Corp. II Class A Common Stock positions in Q2 2022 and 9 closed out, a net change of -1 holder.
- The largest Research Alliance Corp. II Class A Common Stock buyer in Q2 2022 was Saba Capital Management, an estimated $18.7M added.
- The largest Research Alliance Corp. II Class A Common Stock seller in Q2 2022 was HealthCor Management, an estimated $12.9M sold.
Based on aggregated 13F filings for Q2 2022.